F Piovella

Author PubWeight™ 49.51‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Compression ultrasonography for diagnostic management of patients with clinically suspected deep vein thrombosis: prospective cohort study. BMJ 1998 6.07
2 Travel and risk of venous thrombosis. Lancet 2000 5.23
3 Treatment of venous thrombosis with intravenous unfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weight heparin administered at home. The Tasman Study Group. N Engl J Med 1996 4.10
4 Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. N Engl J Med 2003 3.94
5 Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery. N Engl J Med 1998 2.03
6 A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost 2005 1.70
7 Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis. Am J Med 1996 1.45
8 The ultrastructural localization of factor VIII-antigen in human platelets, megakaryocytes and endothelial cells utilizing a ferritin-labelled antibody. Br J Haematol 1978 1.21
9 D-dimer testing as an adjunct to ultrasonography in patients with clinically suspected deep vein thrombosis: prospective cohort study. The Multicentre Italian D-dimer Ultrasound Study Investigators Group. BMJ 1998 1.12
10 Ovarian cancer and venous thromboembolic risk. Gynecol Oncol 2005 1.05
11 Plaque composition in plexogenic and thromboembolic pulmonary hypertension: the critical role of thrombotic material in pultaceous core formation. Heart 2002 1.02
12 Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. J Thromb Haemost 2007 1.01
13 Immunofluorescent detection of factor VIII-related antigen in human platelets and megakaryoctes. Haemostasis 1974 1.00
14 Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg 2000 0.98
15 Does the type of hormone replacement therapy influence the risk of deep vein thrombosis? A prospective case-control study. J Thromb Haemost 2005 0.94
16 Can causes of false-normal D-dimer test [SimpliRED] results be identified? Thromb Res 2003 0.94
17 Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 2001 0.92
18 Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax 2002 0.92
19 Safety and sensitivity of two ultrasound strategies in patients with clinically suspected deep venous thrombosis: a prospective management study. J Thromb Haemost 2009 0.89
20 [Clinical course and incidence of post-thrombophlebitic syndrome after profound asymptomatic deep vein thrombosis. Results of a transverse epidemiologic study]. Minerva Cardioangiol 1997 0.85
21 Endothelin and nitric oxide synthase in lymphatic endothelial cells: immunolocalization in vivo and in vitro. Anat Rec 1997 0.85
22 Characterization of procoagulant activity produced by cultures of human monocytes and lymphocytes separated in colloidal silica-polvinylpyrrolidone gradients. Clin Lab Haematol 1980 0.85
23 Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br J Pharmacol 1996 0.84
24 Nicotine alters fibronectin and factor VIII/vWF in human vascular endothelial cells. Br J Haematol 1986 0.80
25 Surgical therapy for chronic thromboembolic pulmonary hypertension: criteria for choosing lung transplant vs trhomboendarterectomy. J Heart Lung Transplant 2001 0.80
26 Alpha-2-macroglobulin may provide protection from thromboembolic events in antithrombin III-deficient children. Blood 1991 0.78
27 Immunohistological comparison of platelet factor 4 (PF4), fibronectin (Fn) and factor VIII related antigen (VIIIR:Ag) in human platelet granules. Br J Haematol 1982 0.78
28 Immunofluorescent detection of alpha 1-antitrypsin in platelets and megakaryocytes. Thromb Res 1977 0.78
29 Centella Asiatica Triterpenic Fraction (CATTF) reduces the number of circulating endothelial cells in subjects with post phlebitic syndrome. Haematologica 1992 0.77
30 Immunolocalization of endothelin and nitric oxide-synthase in lymphatic vessels and cultured lymphatic endothelial cells. Microvasc Res 1997 0.77
31 Congenital antithrombin III deficiency. Incidence and clinical features. Am J Med 1989 0.77
32 Effects of ticlopidine and dexamethasone on fibronectin and factor VIII-related antigen synthesis by cultured endothelial cells. Thromb Res Suppl 1983 0.77
33 Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs. An LDL receptor-independent phenomenon. Arterioscler Thromb 1993 0.76
34 Digital clubbing associated with pulmonary artery sarcoma. Chest 1996 0.76
35 P-selectin and von Willebrand factor in bovine mesenteric lymphatics: an immunofluorescent study. Lymphology 1996 0.76
36 Use of anticoagulants in patients with sepsis. JAMA 2002 0.76
37 The effect of dexamethasone on formation of intra and extracellular fibronectin matrix by human endothelial cells in culture. Haematologica 1982 0.76
38 New agents in medical oncology and the risk of venous thromboembolism. J Exp Clin Cancer Res 2007 0.75
39 Pulmonary thromboendarterectomy in a patient with cryoagglutinins. J Cardiothorac Vasc Anesth 2000 0.75
40 Interactions between tumor cells and vascular endothelium.-I) Adhesion properties of cell lines with different metastasizing capacity. Boll Soc Ital Biol Sper 1983 0.75
41 Characterisation and synthesis of some factor VIII related properties in cultured human endothelial cells. Haematologica 1979 0.75
42 Isolation and growth of human endothelial cells from peripheral blood by PVP-silica density gradients. Boll Soc Ital Biol Sper 1985 0.75
43 Early diagnosis of deep vein thrombosis following total hip replacement using impedance plethysmography: advantages and limitations of this approach. Ital J Orthop Traumatol 1992 0.75
44 Migratory capacity of large granular lymphocytes from T-gamma-lymphoproliferative disorders. Nat Immun Cell Growth Regul 1986 0.75
45 The adhesion of two murine fibrosarcoma cell lines to the endothelial cell extracellular matrix is independent of fibronectin deposition. Haematologica 1988 0.75
46 Effect of endothelial cells on platelet aggregation in platelet rich plasma (PRP) and whole blood. Thromb Res 1990 0.75
47 Basic, laboratory and clinical aspects of thromboembolic diseases. Haematologica 1997 0.75
48 Cost-effectiveness of post-routine screening for an occult cancer in patients with idiopathic venous thromboembolism. Haematologica 1995 0.75
49 [Functional significance of intra-platelet factor VIII-related antigen]. Boll Soc Ital Biol Sper 1977 0.75
50 [B-lymphocytes in multiple sclerosis: studies concerning their levels in the blood and cerebrospinal fluid]. Boll Ist Sieroter Milan 1978 0.75
51 The effect of ticlopidine on human endothelial cells in culture. Thromb Res 1984 0.75
52 Plasma fibronectin, von Willebrand factor antigen, and blood rheology. Association with diabetic microvascular disease. Acta Diabetol Lat 1986 0.75
53 Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. Thromb Haemost 1992 0.75
54 Platelets, megakaryocytes and factor VIII. Haematologica 1978 0.75
55 Factor VIII related antigen in platelets from patients with von Willebrand's disease: a study of eight cases. Haematologica 1976 0.75
56 The epidemiology of deep vein thrombosis and pulmonary embolism. Haematologica 1995 0.75
57 Immunologic studies on platelet antiproteases. Haematologica 1978 0.75
58 Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion. Haematologica 1997 0.75
59 Balanced autosomal translocations and ovarian dysgenesis. Hum Genet 1994 0.75
60 Interactions between tumor cells and vascular endothelium.-II) Light and electron microscopic studies. Boll Soc Ital Biol Sper 1983 0.75
61 [Venous thromboembolism: epidemiology and risk factors]. Minerva Cardioangiol 1996 0.75
62 Synthesis of procoagulant antihaemophilic factor in vitro. Lancet 1978 0.75
63 [Platelet function during pregnancy and delivery in a patient with defective platelet "release reaction"]. Haematologica 1980 0.75
64 Common variable immunodeficiency: long term clinical consequencies of splenectomy in a case of late-onset hypogammaglobulinaemia. Haematologica 1978 0.75
65 Extracellular matrices produced in the presence of dexamethasone: a natural "growth agent" for human cultured endothelium. Boll Soc Ital Biol Sper 1984 0.75
66 On the pathology of haemophilic joints. Pathol Eur 1974 0.75